Cyclophosphamide and other new agents for the treatment of severe aplastic anemia

« PreviousSeminars in Hematology
Volume 37, Issue 1 , Pages 102-109, January 2000

Cyclophosphamide and other new agents for the treatment of severe aplastic anemia☆

John F Tisdale
- Address reprint requests to John F. Tisdale, MD, Bldg 10, Room 9N116, Molecular and Clinical Hematology Branch, National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892.
- From the Molecular and Clinical Hematology Branch, National Insitute of Diabetes and Digestive and Kidney Diseases, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA
- From the Division of Hematology, University of Utah, Salt Lake City, UT, USA
Daniel E Dunn
- From the Molecular and Clinical Hematology Branch, National Insitute of Diabetes and Digestive and Kidney Diseases, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA
- From the Division of Hematology, University of Utah, Salt Lake City, UT, USA
Jaroslaw Maciejewski
- From the Molecular and Clinical Hematology Branch, National Insitute of Diabetes and Digestive and Kidney Diseases, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA
- From the Division of Hematology, University of Utah, Salt Lake City, UT, USA